|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Alberg AJ, Ford JG and Samet JM; American
College of Chest Physicians. Epidemiology of lung cancer: ACCP
evidence-based clinical practice guidelines (2nd edition). Chest.
132(Suppl): 29S–55S. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dela Cruz CS, Tanoue LT and Matthay RA:
Lung cancer: epidemiology, etiology, and prevention. Clin Chest
Med. 32:605–644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van den Akker M, Buntinx F, Metsemakers
JF, Roos S and Knottnerus JA: Multimorbidity in general practice:
prevalence, incidence, and determinants of co-occurring chronic and
recurrent diseases. J Clin Epidemiol. 51:367–375. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yancik R, Ganz PA, Varricchio CG and
Conley B: Perspectives on comorbidity and cancer in older patients:
approaches to expand the knowledge base. J Clin Oncol.
19:1147–1151. 2001.PubMed/NCBI
|
|
7
|
Sharabiani MT, Aylin P and Bottle A:
Systematic review of comorbidity indices for administrative data.
Med Care. 50:1109–1118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Klabunde CN, Potosky AL, Legler JM and
Warren JL: Development of a comorbidity index using physician
claims data. J Clin Epidemiol. 53:1258–1267. 2000. View Article : Google Scholar
|
|
9
|
Read WL, Tierney RM, Page NC, et al:
Differential prognostic impact of comorbidity. J Clin Oncol.
22:3099–3103. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Holman CD, Preen DB, Baynham NJ, Finn JC
and Semmens JB: A multipurpose comorbidity scoring system performed
better than the Charlson index. J Clin Epidemiol. 58:1006–1014.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Charlson ME, Pompei P, Ales KL and
MacKenzie CR: A new method of classifying prognostic comorbidity in
longitudinal studies: development and validation. J Chronic Dis.
40:373–383. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sundararajan V, Henderson T, Perry C, et
al: New ICD-10 version of the Charlson comorbidity index predicted
in-hospital mortality. J Clin Epidemiol. 57:1288–1294. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Quan H, Sundararajan V, Halfon P, et al:
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10
administrative data. Med Care. 43:1130–1139. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stukenborg GJ, Wagner DP and Connors AF
Jr: Comparison of the performance of two comorbidity measures, with
and without information from prior hospitalizations. Med Care.
39:727–739. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kastner C, Armitage J, Kimble A, Rawal J,
Carter PG and Venn S: The Charlson comorbidity score: a superior
comorbidity assessment tool for the prostate cancer
multidisciplinary meeting. Prostate Cancer Prostatic Dis.
9:270–274. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Berlowitz DR, Hoenig H, Cowper DC, et al:
Impact of comorbidities on stroke rehabilitation outcomes: does the
method matter? Arch Phys Med Rehabil. 89:1903–1906. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Armitage JN and van der Meulen JH; Royal
College of Surgeons Co-morbidity Consensus Group. Identifying
co-morbidity in surgical patients using administrative data with
the Royal College of Surgeons Charlson Score. Br J Surg.
97:772–781. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Buttafarano RJ, Piccirillo JF, Meyers BF,
et al: Impact of comorbidity on survival after surgical resection
in patients with stage I non-small cell lung cancer. J Thorac
Cardiovasc Surg. 123:280–287. 2002. View Article : Google Scholar
|
|
19
|
Tammemagi CM, Neslund-Dudas C, Simoff M
and Kvale P: Impact of comorbidity on lung cancer survival. Int J
Cancer. 103:792–802. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ganti AK, Siedlik E, Marr AS, Loberiza FR
Jr and Kessinger A: Predictive ability of the Charlson comorbidity
index on outcomes from lung cancer. Am J Clin Oncol. 34:593–596.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Field JK, Smith DL, Duffy S and Cassidy A:
The Liverpool Lung Project research protocol. Int J Oncol.
27:1633–1645. 2005.PubMed/NCBI
|
|
22
|
Health and Social Care Information Centre.
Support and guidance: Hospital Episode Statistics. www.hscic.gov.uk/hesurisimplewww.hscic.gov.uk/hes.
Accessed 5 December, 2013
|
|
23
|
Lau B, Cole SR and Gange SJ: Competitive
risk regression models for epidemiologic data. Am J Epidemiol.
170:244–256. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim HT: Cumulative incidence in competing
risks data and competing risks regression analysis. Clin Cancer
Res. 13:559–565. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Satagopan JM, Ben-Porat L, Berwick M, et
al: A note on competitive risk in survival data analysis. Br J
Cancer. 91:1229–1235. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lunn M and McNeil D: Applying Cox
regression to competing risks. Biometrics. 51:524–532. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jørgensen TL, Hallas J, Friis S and
Herrstedt J: Comorbidity in elderly cancer patients in relation to
overall and cancer-specific mortality. Br J Cancer. 106:1353–1360.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Asmis TR, Ding K, Seymour L, et al;
National Cancer Institute of Canada Clinical Trials Group. Age and
comorbidity as independent prognostic factors in the treatment of
non small-cell lung cancer: a review of National Cancer Institute
of Canada Clinical Trials Group trials. J Clin Oncol. 26:54–59.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Birim O, Kappetein AP and Bogers AJ:
Charlson comorbidity index as a predictor of long-term outcome
after surgery for nonsmall cell lung cancer. Eur J Cardiothorac
Surg. 28:759–762. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Williams JG and Mann RY: Hospital episode
statistics: time for clinicians to get involved? Clin Med. 2:34–37.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
de Groot V, Beckerman H, Lankhorst GJ and
Bouter LM: How to measure comorbidity. A critical review of
available methods. J Clin Epidemiol. 56:221–229. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pirie K, Peto R, Reeves GK, Green J and
Beral V; Million Women Study Collaborators. The 21st century
hazards of smoking and benefits of sptopping: a prospective study
of one million women in the UK. Lancet. 381:133–141. 2013.
View Article : Google Scholar :
|
|
33
|
National Cancer Intelligence Network.
http://www.ncin.org.uk/cancer_information_tools/eatlas/pct/atlas.html?select=Eav&indicator=i0.
Accessed 5 December, 2013
|
